Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin

@article{Liu2016EpigeneticAO,
  title={Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin},
  author={Y. Liu and X. Zheng and Qinqin Yu and H. Wang and F. Tan and Qianying Zhu and Lingmin Yuan and Huidi Jiang and L. Yu and S. Zeng},
  journal={Science Translational Medicine},
  year={2016},
  volume={8},
  pages={348ra97 - 348ra97}
}
  • Y. Liu, X. Zheng, +7 authors S. Zeng
  • Published 2016
  • Biology, Medicine
  • Science Translational Medicine
  • The expression of drug transporter OCT2 is suppressed in renal cell carcinoma, and targeting this pathway sensitizes the tumor to oxaliplatin. Opening a door into cancer cells Renal cell carcinoma is a common cancer that is often resistant to chemotherapy. To address this, Liu et al. investigated the role of OCT2, a protein that normally transports oxaliplatin, a common chemotherapy drug, into cells. The authors found that OCT2 was epigenetically silenced in renal cancer and figured out the… CONTINUE READING
    45 Citations
    Kidney cancer: OCT2 demethylation cracks open oxaliplatin resistance
    • 2
    Upregulation of miR-489-3p and miR-630 inhibits oxaliplatin uptake in renal cell carcinoma by targeting OCT2
    • 10
    Regulation of OCT2 transcriptional repression by histone acetylation in renal cell carcinoma
    • 8
    The failure of DAC to induce OCT2 expression and its remission by hemoglobin-based nanocarriers under hypoxia in renal cell carcinoma
    • 1
    • PDF
    MT2A Promotes Oxaliplatin Resistance in Colorectal Cancer Cells
    Epigenetic Mechanisms Underlying Organic Solute Transporter β Repression in Colorectal Cancer
    • 1
    The Role of DNA Methylation in Renal Cell Carcinoma
    • 4
    The Drug-Resistance Mechanisms of Five Platinum-Based Antitumor Agents
    • 6
    • PDF

    References

    SHOWING 1-10 OF 54 REFERENCES
    Resistance to Targeted ABC Transporters in Cancer
    • T. Efferth
    • Medicine
    • Resistance to Targeted Anti-Cancer Therapeutics
    • 2015
    • 13
    Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity.
    • 195
    • Highly Influential
    Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2
    • 95
    • PDF
    Kidney-specific expression of human organic cation transporter 2 (OCT2/SLC22A2) is regulated by DNA methylation.
    • 66
    • PDF
    Gene Signatures of Progression and Metastasis in Renal Cell Cancer
    • 342
    • PDF